Superworth

Trevi Therapeutics market cap TRVI

Share price times shares outstanding: what the whole company sells for, since 2019.

Today, Nov 2, 2026
$1.9B
Highest close in our data
$2.7B
Jul 2026

Trevi Therapeutics is worth $1.9B at the close on Nov 2, 2026, at $13.63 a share.

That is up 45% over the last year and up 7585% over five years.

Its highest close in our data was $2.7B in Jul 2026.

Market cap over time

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHighChange
2026 so far$1.9B$1.3B$2.7B+18%
2025$1.6B$289M$1.7B+402%
2024$328.2M$84.3M$328.2M+284%
2023$85.6M$70.9M$206.6M−26%
2022$115.7M$12.9M$175.8M+472%
2021$20.2M$17.9M$62.3M−55%
2020$44.5M$41M$135.8M−33%
2019$66.3M$49.6M$152.8Mn/a

Against its peers

Companies in Drug Manufacturers - General nearest Trevi Therapeutics' size, closest first, today.

What the market cap tells you

Share price times shares outstanding: what the whole company sells for today.

Size, not quality. Large caps move slower and are covered more. That is all it tells you.

More on Trevi Therapeutics

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.